Literature DB >> 6497890

Blood group A glycolipid (Ax) with globo-series structure which is specific for blood group A1 erythrocytes: one of the chemical bases for A1 and A2 distinction.

H Clausen, K Watanabe, R Kannagi, S B Levery, E Nudelman, Y Arao-Tomono, S Hakomori.   

Abstract

A new blood group A-active glycolipid fraction, termed Ax, showing a chromatographic mobility between Aa and Ab was found in blood group A1 erythrocytes but not in A2 erythrocytes. Ax was identified by its conversion to "globo H" by alpha-N-acetylgalactosaminidase and by 1H-NMR spectroscopy as GalNAc alpha l----3[Fuc alpha l----2]Gal beta l----3GalNAc beta l----3Gal alpha l----4Gal beta l----4Glc beta l----lCer. Globo-H (Fuc alpha l----2Gal beta l----3GalNac beta l----3Gal alpha l----4Gal beta l----4Glc beta l----lCer) was found in blood group A, and O but not in A1 erythrocytes. Thus, one of the A1-specific determinants must be an A determinant carried by globo-series structure.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6497890     DOI： 10.1016/0006-291x(84)91585-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


  11 in total

1.  pap-2-encoded fimbriae adhere to the P blood group-related glycosphingolipid stage-specific embryonic antigen 4 in the human kidney.

Authors:  J F Karr; B J Nowicki; L D Truong; R A Hull; J J Moulds; S I Hull
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

2.  Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: chemical basis of qualitative A1 and A2 distinction.

Authors:  H Clausen; S B Levery; E Nudelman; S Tsuchiya; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

3.  Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate.

Authors:  V Kudryashov; G Ragupathi; I J Kim; M E Breimer; S J Danishefsky; P O Livingston; K O Lloyd
Journal:  Glycoconj J       Date:  1998-03       Impact factor: 2.916

4.  Detection of ABO blood group-active glycolipids extracted from red cell membrane and heat hematoma using TLC-immunostaining.

Authors:  M Ota; H Fukushima; I Yonemura; H Hasekura
Journal:  Z Rechtsmed       Date:  1988

5.  Blood group type glycosphingolipids of human kidneys. Structural characterization of extended globo-series compounds.

Authors:  J Holgersson; P A Jovall; B E Samuelsson; M E Breimer
Journal:  Glycoconj J       Date:  1991-10       Impact factor: 2.916

6.  Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status.

Authors:  A Stapleton; E Nudelman; H Clausen; S Hakomori; W E Stamm
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Norwalk virus-like particles bind specifically to A, H and difucosylated Lewis but not to B histo-blood group active glycosphingolipids.

Authors:  Jonas Nilsson; Gustaf E Rydell; Jacques Le Pendu; Göran Larson
Journal:  Glycoconj J       Date:  2009-12       Impact factor: 2.916

8.  Structural characterization of blood group A glycosphingolipids recognized by the antibody 3G9-A.

Authors:  J B Briggs; R Mandrell; B A Macher
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

9.  Recognition of blood group ABH type 1 determinants by the FedF adhesin of F18-fimbriated Escherichia coli.

Authors:  Annelies Coddens; Mette Diswall; Jonas Angström; Michael E Breimer; Bruno Goddeeris; Eric Cox; Susann Teneberg
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

10.  Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen.

Authors:  S Hirohashi; H Clausen; T Yamada; Y Shimosato; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.